BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1479234)

  • 1. [Countermeasure for infections with granulocytopenia].
    Sotoyama K
    Nihon Naika Gakkai Zasshi; 1992 Nov; 81(11):1876-81. PubMed ID: 1479234
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bacterial sepsis in the hematologic neutropenic patient].
    Todeschini G; Benato G; Carlini S; Veneri D
    Haematologica; 1989 Oct; 74(5 Suppl):297-309. PubMed ID: 2480272
    [No Abstract]   [Full Text] [Related]  

  • 3. Recovery of carbimazole-induced agranulocytosis following recombinant granulocyte-macrophage colony stimulating factor (rhGM-CSF) administration.
    Meletis J; Vavourakis S; Andreopoulos T; Yataganas X; Poziopoulos C; Lafioniatis S; Konstantopoulos K; Loukopoulos D
    Haematologica; 1993; 78(5):329-31. PubMed ID: 8314163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug therapy of bacterial infections in patients with granulocytopenia].
    Masaoka T
    Nihon Naika Gakkai Zasshi; 1990 Dec; 79(12):1653-6. PubMed ID: 1706748
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hematopoietic growth factors as supportive treatment in drug-induced agranulocytosis].
    Hospers GA; de Wolf JT; Hazenberg BP; Vellenga E
    Ned Tijdschr Geneeskd; 1993 Oct; 137(42):2152-4. PubMed ID: 7694163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of drug-induced agranulocytosis with colony stimulating factors (G-CSF or GM-CSF).
    Góra-Tybor J; Krykowski E; Robak T
    Arch Immunol Ther Exp (Warsz); 1996; 44(4):255-8. PubMed ID: 9017166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sargramostim for sulfasalazine-induced agranulocytosis.
    Rospond RM; Glowacki RC; Mailliard JA
    Clin Pharm; 1993 Mar; 12(3):179. PubMed ID: 8098278
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of haematopoietic growth factors granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the management of drug-induced agranulocytosis.
    Andrès E; Maloisel F; Zimmer J
    Br J Haematol; 2010 Jul; 150(1):3-8. PubMed ID: 20151980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molgramostim (GM-CSF) associated with antibiotic treatment in nontraumatic abdominal sepsis: a randomized, double-blind, placebo-controlled clinical trial.
    Orozco H; Arch J; Medina-Franco H; Pantoja JP; González QH; Vilatoba M; Hinojosa C; Vargas-Vorackova F; Sifuentes-Osornio J
    Arch Surg; 2006 Feb; 141(2):150-3; discussion 154. PubMed ID: 16490891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant granulocyte colony-stimulating factor (G-CSF) in infectious diseases: still a debate.
    Wiedermann FJ; Mittermayr M; Hoffmann G; Schobersberger W
    Wien Klin Wochenschr; 2001 Feb; 113(3-4):90-6. PubMed ID: 11253746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of diflucan in myelotoxic agranulocytosis].
    Kliasova GA
    Ter Arkh; 1993; 65(7):81-3. PubMed ID: 8211788
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diagnosis and management of infections complicated with hematological diseases].
    Toyama K
    Nihon Naika Gakkai Zasshi; 1991 Sep; 80(9):1485-90. PubMed ID: 1722236
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
    Yoshida M; Karasawa M; Naruse T; Fukuda M; Hirashima K; Oh H; Ninomiya H; Abe T; Saito K; Shishido H; Moriyama Y; Shibata A; Motoyoshi K; Nagata N; Miura Y
    Int J Hematol; 1999 Feb; 69(2):81-8. PubMed ID: 10071455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Infection in the granulocytopenic patient].
    Cajozzo A
    Haematologica; 1989 Oct; 74(5 Suppl):275-7. PubMed ID: 2512213
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful treatment of chronic disseminated candidiasis with fluconazole and a granulocyte-macrophage colony-stimulating factor combination.
    Rókusz L; Liptay L; Kádár K
    Scand J Infect Dis; 2001; 33(10):784-6. PubMed ID: 11728053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined cephalosporin aminoglycoside therapy in gram-negative sepsis. The choice of cephalosporin.
    Mészáros J; Tołłoczko T; Stachlewska E; Tyc Z; Jeljaszewicz J
    J Chemother; 1989 Jul; 1(4 Suppl):828-9. PubMed ID: 16312658
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of recombinant human granulocyte-macrophage colony-stimulating factor as treatment for aplastic anemia and agranulocytosis.
    Champlin RE; Nimer SD; Oette D; Golde DW
    Prog Clin Biol Res; 1990; 338():143-50. PubMed ID: 2189137
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of methimazole-induced agranulocytosis with granulocyte-macrophage colony stimulating factor].
    Somogyi A; Werling K; Rosta A; Láng I
    Orv Hetil; 1994 Nov; 135(45):2483-5. PubMed ID: 7991239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Miconazole treatment of candida sepsis in aminophenazone induced agranulocytosis.
    Evers KG; Knoop UF
    Acta Paediatr Belg; 1978; 31(3):151-3. PubMed ID: 707093
    [No Abstract]   [Full Text] [Related]  

  • 20. Approach to the management of fever and granulocytopenia.
    Delgado DG; Cobbs CG
    South Med J; 1980 May; 73(5):627-30. PubMed ID: 7375983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.